...
首页> 外文期刊>Acta physiologica >Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart.
【24h】

Effects of potassium channel openers in the isolated perfused hypokalaemic murine heart.

机译:钾通道开放剂在离体灌注低血钾小鼠心脏中的作用。

获取原文
获取原文并翻译 | 示例

摘要

AIM: We explored the anti-arrhythmic efficacy of K(+) channel activation in the hypokalaemic murine heart using NS1643 and nicorandil, compounds which augment I(Kr) and I(KATP) respectively. METHODS: Left ventricular epicardial and endocardial monophasic action potentials were compared in normokalaemic and hypokalaemic preparations in the absence and presence of NS1643 (30 microM) and nicorandil (20 microM). RESULTS: Spontaneously beating hypokalaemic hearts (3 mM K(+)) all elicited early afterdepolarizations (EADs) and episodes of ventricular tachycardia (VT). Perfusion with NS1643 and nicorandil suppressed EADs and VT in 7 of 13 and five of six hypokalaemic hearts. Provoked arrhythmia studies using programmed electrical stimulation induced VT in all hypokalaemic hearts, but failed to do so in 7 of 13 and five of six hearts perfused with NS1643 and nicorandil respectively. These anti-arrhythmic effects were accompanied by reductions in action potential duration at 90% repolarization (APD(90)) and changes in the transmural gradient of repolarization, reflected in DeltaAPD(90). NS1643 and nicorandil reduced epicardial APD(90) from 68.3 +/- 1.1 to 56.5 +/- 4.1 and 51.5 +/- 1.5 ms, respectively, but preserved endocardial APD(90) in hypokalaemic hearts. NS1643 and nicorandil thus restored DeltaAPD(90) from -9.6 +/- 4.3 ms under baseline hypokalaemic conditions to 3.9 +/- 4.1 and 9.9 +/- 2.1 ms, respectively, close to normokalaemic values. CONCLUSION: These findings demonstrate, for the first time, the anti-arrhythmic efficacy of K(+) channel activation in the setting of hypokalaemia. NS1643 and nicorandil are anti-arrhythmic through the suppression of EADs, reductions in APD(90) and restorations of DeltaAPD(90).
机译:目的:我们使用NS1643和尼可地尔(分别增加I(Kr)和I(KATP)的化合物)探讨了低血钾鼠心脏中K(+)通道激活的抗心律失常功效。方法:比较了在不存在和存在NS1643(30 microM)和尼可地尔(20 microM)的正常和低血钾制剂中左心室心外膜和心内膜单相动作电位。结果:自发性地跳动低钾血症性心脏(3 mM K(+))均引起早期除极后(EAD)和室性心动过速(VT)发作。在13名低钾血症患者中,有7名和5名中的5名心脏灌注了NS1643和尼可地尔抑制了EAD和VT。使用程序性电刺激在所有低钾血症性心脏中引发心律不齐的研究,但在分别灌注NS1643和尼可地尔的13例心脏中的7例和6例心脏中的5例中没有这样做。这些抗心律失常作用伴随着90%复极(APD(90))时动作电位持续时间的减少和DeltaAPD(90)反映的复极透壁梯度的变化。 NS1643和nicorandil将心外膜APD(90)分别从68.3 +/- 1.1降至56.5 +/- 4.1和51.5 +/- 1.5 ms,但在低钾血症性心脏中保留了心内膜APD(90)。因此,NS1643和尼可地尔将基线低钾血症条件下的DeltaAPD(90)从-9.6 +/- 4.3 ms恢复到3.9 +/- 4.1和9.9 +/- 2.1 ms,分别接近正常血钾值。结论:这些发现首次证明在低钾血症的情况下K(+)通道激活的抗心律不齐功效。 NS1643和尼可地尔可通过抑制EAD,降低APD(90)和恢复DeltaAPD(90)来抗心律失常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号